PULM - Pulmatrix, Inc.
7.39
0.610 8.254%
Share volume: 16,069
Last Updated: 03-11-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$6.78
0.61
0.09%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-10-2024 | 08-10-2023 | 11-09-2023 | 11-08-2024 | 05-10-2024 | 08-13-2024 | 11-08-2024 | |
| Assets | ||||||||
| Total Assets | 36.059 M | 31.393 M | 36.770 M | 33.958 M | 30.391 M | 15.780 M | 11.510 M | |
| Current Assets | 32.800 M | 27.381 M | 23.229 M | 20.843 M | 17.582 M | 15.636 M | 11.446 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 30.753 M | 25.791 M | 21.336 M | 19.173 M | 16.300 M | 12.379 M | 10.782 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 203.000 K | 279.000 K | 1.166 M | 1.158 M | 1.108 M | 0.000 | 0.000 | |
| Other Assets | 3.056 M | 3.733 M | 12.375 M | 11.957 M | 11.701 M | 144.000 K | 64.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 36.059 M | 31.393 M | 36.770 M | 33.958 M | 30.391 M | 15.780 M | 11.510 M | |
| Total liabilities | 9.049 M | 7.944 M | 16.889 M | 15.963 M | 11.373 M | 2.470 M | 590.000 K | |
| Total current liabilities | 4.732 M | 3.597 M | 4.429 M | 3.909 M | 3.144 M | 2.470 M | 590.000 K | |
| Accounts Payable | 578.000 K | 929.000 K | 707.000 K | 1.915 M | 721.000 K | 393.000 K | 373.000 K | |
| Other liabilities | 0.000 | 0.000 | 8.422 M | 8.327 M | 8.229 M | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 8.422 M | 8.327 M | 8.229 M | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 27.010 M | 23.449 M | 19.881 M | 17.995 M | 19.018 M | 13.310 M | 10.920 M | |
| Common stock | 304.934 M | 305.189 M | 305.395 M | 305.592 M | 305.790 M | 305.893 M | 306.090 M | |
| Retained earnings | -277.924 M | -281.740 M | -285.514 M | -287.597 M | -286.772 M | -292.583 M | -295.170 M |